Objective : The objective of this study was to find out the clinical variables correlated with repeated intra-arterial (IA) nimodipine infusions in patients with medically refractory cerebral vasospasm (CV) following subarachnoid hemorrhage (SAH).
INTRODUCTION
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MATERIALS AND METHODS

Patient population
During the 36 months between January 2011 and December 2013, 275 patients were treated at our institute for SAH due to a ruptured intracranial aneurysm.
Among the 275 patients, 26 patients (9.5%) had findings compatible with symptomatic CV. IA nimodipine infusions were used as routine endovascular treatment for symptomatic CV in these patients. Their medical records were reviewed retrospectively. In all patients, aneurysm treatment was performed within the first 24 hours after hemorrhage. All standard medical treatments for CV prevention were performed in the neurosurgical intensive care unit, including triple-H therapy. At admission, the neurologic and clinical conditions of patients were assessed using the Glasgow coma scale (GCS) scores and with the Hunt-Hess grading scale.
The amount of SAH on CT image was evaluated using the Fisher grade. The clinical characteristics of the patients are summarized in Table 1 .
Application for angioplasty
When vasospasm was suspected, a brain CT or dif- 
Clinical evaluation
Based on the clinical charts, the GCS scores and clinical symptoms (including confusion, headache, vomiting, dizziness, and neurologic deficit) before and after each IA nimodipine infusion were assessed. Patient outcomes at 1 month and 3 months after angioplasty were assessed by the Glasgow outcome scale (GOS) score.
Clinical outcomes of 26 patients treated with first IA nimodipine infusion are summarized in Table 2 .
TCD evaluation
Serial TCD studies of MCA blood flow velocity were performed daily from the day of admission.
Mean MCA velocity (cm/sec) was recorded daily through a temporal window using a 2-MHz transducer (MultiDop P; DWL, Uberlingen, Germany).
Angiographic evaluation
The vessel diameters of the terminal(communicat- The number of affected vessel segments was de- 
RESULTS
Clinical characteristics
This study included 26 patients (12 
Angiographic results
In single infusion patients, most CV occurred at the proximal vessels in 10 of 11 patients (90.9%), at the distal vessels in one patient (9.1%), and at both proximal and distal vessels in zero patients. In multiple infusion patients, the proximal and distal vessels were 
TCD findings
There are many published studies about using TCD for CV diagnosis after SAH. However, data is lacking on TCD findings before and after endovascular treat- 
Multiple IA nimodipine infusion patients
In multiple infusion patients, vasospasm occurred more diffusely, bilaterally, and distally. The number of spastic vessel segments was associated with the necessity for multiple infusions. Improvement in GCS score after the first angioplasty was poorer in multiple infusion patients than single infusion patients.
Only 2 of 15 patients (13.3%) showed GCS score improvement after first angioplasty.
After the first angioplasty, spastic vessels dilated from 52.1 to 77.6% on average. However, treated vessels narrowed from 77.6 to 56.0% on the following day. Spastic vessels dilated again from 56.0 to 77.3%
after the second angioplasty. Immediate angiographic response to first and second infusions did not differ.
It was difficult to discern if the results were purely This study has some limitations. Data collection was retrospective. The number of patients was relatively small, which may lead to statistical misinterpretation.
The primary goal of endovascular treatment for symptomatic vasospasm is to increase cerebral blood flow to prevent infarction, yet infarction rate due to vasospasm was not included.
CONCLUSION
Based on our study, following factors were related with multiple IA nimodipine infusions: 1) no improvement in GCS after the IA nimodipine infusion; 2) no decrease of MCA velocity on TCD over 50 cm/s or Lindegaard ratio over 4.3 after the IA nimodipine infusion; 3) distal, bilateral, or diffuse involvement of CV.
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